Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 108
Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
---|---|---|---|---|
Preclinical Efficacy Validation In Non-Human Primate Stroke Model Of Anti-Thrombin-Clot Specific Streptokinase (ACSSK), With Dual Properties Of Fibrin Specific Clot Dissolution And Prevention Of Arterial Re-Occlusion, For The Treatment Of Acute Myocardial Infarction And Ischemic Stroke | Dr Yogendra Padwad, Scientist, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Pre-clinical validation on non-human primates for heart diseases |
Re-purposing of FDA drugs and exploitation of ancient Ayurvedic knowledge to discover novel inhibitors to block coronavirus propagation | Dr Vishal Trived, Associate Professor, Indian Institute of Technology (IIT) Guwahati | 2020 | Drug repurposing for COVID-19 | |
Towards large scale Production of Recombinant Proteins for Vaccine and Testing of Novel COVID-19 to produce reagents for the development of indigenous vaccine | Prof Sudip K. Ghosh, Ananta K. Ghosh, Professor, Ramkrishna Sen, Professor, Indian Institute of Technology (IIT) Kharagpur | 2020 | Vaccine development for COVID-19 | |
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells | Dr Mirza S Baig, Associate Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
Development of process for production of 4-methoxy acetophenone in a continuous single-step process | Dr Pravin R. Likhar, Scientist, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Agrochemicals & Pharmaceuticals |
Virtual Screening and in vitro validation of SARS CoV-II Main Protease inhibitors | Dr Sharad Gupta, Associate Professor, Dr Mithun Radhakrishna, Assistant Professor, Indian Institute of Technology (IIT) Gandhinagar | 2020 | Drug repurposing for COVID-19 | |
In-Vitro Fluorescence Microscopy Studies Show Retention of Spike-Protein (SARS-CoV-2) on Cell Membrane in the Presence of Amodiaquin Dihydrochloride Dihydrate Drug | Prof Partha Mondal, Indian Institute of Science (IISc), Bengaluru | 2020 | Drug repurposing for COVID-19 | |
Neutralizing Peptide Antibody Designed for Human Complement Fragment 5a (hC5a) | Dr Soumendra Rana, Assistant Professor, Indian Institute of Technology (IIT) Bhubaneswar | 2020 | Drug repurposing for COVID-19 | |
Adapt Ubiqare?s Specialty Care Platform to take care of COVID-19 patients during home quarantine and isolation ward stage | Sundararajan Srinivasan, Co-founder & CMD, ?Ubiqare Health Pvt Ltd, Bengaluru | 2020 | Specialty Care Platform for covid patients | |
Preparation of Disease management Manual for Primary Health Centers (PHCs) and Hospitals | Prof Satadal Saha, Indian Institute of Technology (IIT) Kharagpur, Prof Dipankar Bandyopadhyay, Indian Institute of Technology (IIT) Guwahati | 2020 | Management of Primary Health Centres |